Plant extract export rise concerns related companies

Business Club reported on May 27 that in the first quarter of 2011, the export of plant extracts in China was different from normal, and there was a "blowout phenomenon" Among the listed companies, there were Jiaotong University onli, Kangenbei and other companies involved in plant extracts The organizer of the 11th world pharmaceutical raw materials China Exhibition said in Shanghai on the 24th that it should have been the first quarter of the off-season for the export of plant extracts, but this year showed different characteristics from previous years, with a substantial increase on a year-on-year basis According to the statistics of China Customs, in the first quarter of 2011, China's import and export of plant extracts reached US $310 million, an increase of 46.4% year on year Among them, the export volume was US $270 million, an increase of 53.4% year on year, and the proportion of plant extracts in the export of traditional Chinese medicine products gradually increased In the first quarter of this year, EU market became the most eye-catching export market of plant extracts European Union countries, mainly Germany, Spain and the United Kingdom, saw an increase of nearly or more than 100% in the import of Chinese plant extracts in the first quarter After the export of traditional Chinese patent medicines is weakened, the market will increase the demand for plant extracts, which leaves a huge growth space for the export of plant extracts in China, and is one of the main reasons for the multiple growth of plant extracts export to the EU in the first quarter Plant extract can be used as a kind of API, and it can be used as medicine or health care product after further processing, which is a necessary stage before Chinese patent medicine product In recent years, due to the time limit of traditional Chinese medicine resources, the price of traditional Chinese medicine has increased several times, and the export price of traditional Chinese medicine is bound to rise At present, the weakening export of Chinese patent medicine and the rising demand for plant extracts may be the performance of reducing the cost of Chinese patent medicine in foreign market Listed companies related to botanical drugs include: ANGLI, Chenguang biology, Kangenbei, Rhine biology, Tianshili, Huabei pharmaceutical, etc Among them, Shanghai Nord Biotechnology Industry Co., Ltd., a subsidiary of ANGLI, Jiaotong University, is one of the top ten companies in the world in 10 years The company's management, market and scientific research headquarters are located in Shanghai, and the production entity is the original Hunan Jinnong biological resources Co., Ltd the scale of Hunan Jinnong's assets is close to 200 million, and the maximum sales volume is close to 100 million In 2005, Mitsui agroforestry Co., Ltd., a Japanese investor, was introduced and became a foreign-funded enterprise The technical force of Nord company comes from the Research Institute of ANGLI, Jiaotong University, which has a postdoctoral mobile site, and Hunan Agricultural University Its main products include tea polyphenols, Siraitia fruit extract, artemisinin, etc After two years of resource integration, ANGLI of Jiaotong University has transformed the former passive marketing mode of Hunan Jinnan only through foreign trade export into active marketing mode It has established sales offices in the United States, cooperated with local companies in Canada, established a global R & D center, and established a long-term cooperative relationship with large foreign health food and consumer goods companies Chenguang biology: the company is an export-oriented enterprise integrating the deep processing of agricultural products and the extraction of natural plants It is mainly engaged in the research and production of natural pigment, natural spice extract and essential oil, natural nutrition and medicinal extract Among them, the production and sales of natural pigment ranks the first in China and the first in the world It is the largest production and supply of capsanthin in the world Shang Kangenbei: the leading product is ginkgo biloba extract, "Tianbaoning" Ginkgo biloba leaf, a listed company, the first company to develop ginkgo biloba preparation in China, acquired Hunan Jiuhui modern Chinese medicine company in 2005, and further expanded the plant extract field Rhine biology: the main products are grape seed extract, Rhodiola extract, Siraitia extract, etc Now we are cooperating with MB North American to develop the North American market In the industry, the company is one of the enterprises capable of producing the most complete varieties of plant extracts in China It has mastered the production technology of more than 200 kinds of plant extracts, of which more than 60 products have been strictly tested by foreign independent testing institutions, which can quickly and flexibly adjust the varieties of biological products according to the market demand, with the market adaptability leading the industry; the product structure is relatively diversified, single The proportion of main products in the company's sales volume is generally less than 20%, which can effectively disperse market risk Tianshili: plant extracts and preparations, including Tianshi tea, pu'aining, pollen tea, Tianshi Fuxin and other health products The first pharmaceutical enterprise in China that has passed the integration and certification of international standard system; the specialized standardized digital plant medicine extraction enterprise.